Many physiologically based pharmacokinetic (PBPK) models for environmental chemicals, drugs, and nanomaterials have been developed to aid risk and safety assessments using acslX. However, acslX has been rendered sunset since November 2015. Alternative modeling tools and tutorials are needed for future PBPK applications. This forum article aimed to: (1) demonstrate the performance of 4 PBPK modeling software packages (acslX, Berkeley Madonna, MATLAB, and R language) tested using 2 existing models (oxytetracycline and gold nanoparticles); (2) provide a tutorial of PBPK model code conversion from acslX to Berkeley Madonna, MATLAB, and R language; (3) discuss the advantages and disadvantages of each software package in the implementation of PBPK models in toxicology, and (4) share our perspective about future direction in this field. Simulation results of plasma/tissue concentrations/amounts of oxytetracycline and gold from different models were compared visually and statistically with linear regression analyses. Simulation results from the original models were correlated well with results from the recoded models, with time-concentration/amount curves nearly superimposable and determination coefficients of 0.86-1.00.
provides suggestions for selecting a suitable tool for future projects, and may lead to the transition from acslX to alternative modeling tools.
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Physiologically based pharmacokinetic (PBPK) modeling is a commonly used computational method in pharmacology and toxicology that describes the absorption, distribution, metabolism, and elimination of various chemicals in the body based on interrelationships among key physiological, biochemical, and physicochemical determinants (Bischoff, 1980; Ramsey and Andersen, 1984; Teorell, 1937; WHO, 2010; Yang et al., 1995) . PBPK models have wide applications, including drug discovery and development (Jones et al., 2015; Rowland et al., 2011) , the design of drug therapeutic regimens (Lin et al., 2015a; Moss et al., 2015) , drug withdrawal interval estimation (Buur et al., 2006; Lin et al., 2016a; Riviere et al., 2016) , and risk assessment of environmental toxicants and nanomaterials (Andersen et al., 1987; Andersen and Krishnan, 1994; Breckenridge et al., 2016; Campbell et al., 2016; Fisher et al., 1998; Li et al., 2010; Lin et al., 2015b; Mumtaz et al., 2012a; Reddy et al., 2005; Smith et al., 2014; Yang et al., 2015a) .
Typically, a PBPK model for a particular compound is built using programming software, such as acslX (AEgis Technologies Group, Huntsville, Alabama, USA), Berkeley Madonna (University of California at Berkeley, California, USA), MATLAB (The MathWorks, Inc., Natick, Massachusetts, USA), and R language, among which acslX was the most commonly used PBPK modeling tool in the fields of toxicology, risk assessment (Lin et al., 2013; Martin et al., 2015; Reddy et al., 2005; Teeguarden et al., 2013; Yang et al., 2015b; Yoon et al., 2011) , and veterinary pharmacology (Buur et al., 2006; Craigmill, 2003; Lin et al., 2016d; Yang et al., 2014a) . These software systems are based on different computer languages (ie, semantics and syntax), thus the conversion of a PBPK model between different software is not straightforward. As a result, pharmacologists, toxicologists, and health risk assessors usually need to learn specific program attributes in order to know how to apply PBPK models built on an unfamiliar programming language. Therefore, the translation of PBPK model codes has become a critical issue limiting PBPK model application; this limitation has been emphasized in workshop reports by a panel of PBPK experts (Loizou et al., 2008; McLanahan et al., 2012) and also in a series of publications from the Agency for Toxic Substances and Disease Registry (el-Masri et al., 2002; Ruiz et al., 2010 Ruiz et al., , 2011 Ruiz et al., , 2014 Mumtaz et al., 2012a,b) .
AEgis Technologies Group announced that acslX support and sales would be discontinued in November 2015. All published PBPK models using acslX will require recoding in a different software program and for future applications, new models need to be constructed using alternative tools. Given this situation, the Society of Toxicology (SOT) Biological Modeling Specialty Section (BMSS) has organized a series of webinars introducing various alternative modeling platforms. However, there are no articles detailing how to convert PBPK model codes between different language platforms. To our knowledge, there are no published performance assessments on these popular software packages.
To help address the PBPK model code translation issues and facilitate the transition of model coding from acslX to other software platforms for future toxicology and risk assessment applications, the objectives of this forum article were: (1) to demonstrate the performance of the 4 PBPK modeling software tested using 2 existing models from our laboratory, oxytetracycline and gold nanoparticles; (2) to provide a tutorial on how to convert PBPK model code from acslX to Berkeley Madonna, MATLAB, and R language; (3) to discuss the strengths and weaknesses of each software platform in the applications of PBPK models; and (4) to share the authors' perspectives about the future direction in this field. Recently published PBPK models for oxytetracycline and gold nanoparticles (Figure 1 ; representatives of small molecules and nanomaterials, respectively) using acslX were selected as examples because these models include multiple routes of exposure (ie, IV, IM, oral, and SC) and have been validated for route-, dose-, and species-extrapolation using independent data (Lin et al., 2015a (Lin et al., , 2016b . This tutorial can also be a case study for beginners to learn PBPK modeling.
TRANSLATION OF MODEL CODES FROM ACSLX TO BERKELEY MADONNA, MATLAB, AND R LANGUAGE
In general, the PBPK modeling process includes several common modeling steps as listed in Figure 2 regardless of the software used. However, for each modeling step the specific-coding method can be different between software systems. Table 1 lists an overall comparison of the coding methods for several key modeling steps across the 4 program systems. Detailed descriptions of PBPK model code conversions from acslX to the other 3 software programs are provided in the Supplementary Data. Readers are also encouraged to watch the SOT BMSS webinars (Buyukozturk and Paxson, 2016; Hinderliter and Ruark, 2016; Loizou, 2016; McDougall, 2016; Phillips, 2016; Setzer, 2016) for additional information not covered in this article.
Note that there are many different approaches to recode PBPK models. We are showing one approach using 2 case examples. Recently, a series of physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) models (or termed biologically based dose response models) for the thyroid system and perchlorate in rats and humans of different ages that were originally coded in acslX McLanahan et al., 2008; Fisher et al., 2012 Fisher et al., , 2013 have been converted to R language (EPA, 2016) . These works also provide examples regarding how to convert PBPK models from acslX to R language (EPA, 2016) . Representative PBPK model codes for oxytetracycline and gold nanoparticles in acslX, Berkeley Madonna, MATLAB, and R language are provided in the Supplementary Data. Example acslX executable runtime files or MATLAB files are also provided in Supplementary Data. These example files are compiled together into a single Word document. Individual files in softwarespecific formats are available upon request.
Comparisons of simulation results (ie, model outputs) of oxytetracycline plasma concentrations following a single IV injection (5 mg/kg) and a single oral exposure (100 mg/kg) in dogs between the original acslX model and our recoded models are shown in Figures 3A and B PCs, phagocytic cells. These PBPK model structures were adapted from our earlier publications (Lin et al. 2015a; 2016b) .
FIG. 2.
A general flowchart of the common modeling steps among the 4 PBPK modeling systems. These 4 programming systems include acslX, Berkeley Madonna, MATLAB, and R language. The overall differences in the PBPK model coding among these 4 systems are listed in Table 1 and explained in detail in the text. PBPK, physiologically based pharmacokinetic.
between acslX and Berkeley Madonna results, between acslX and MATLAB results, between acslX and R language results were 1.00, 0.87, and 1.00, respectively, for the IV exposure simulation (5 mg/kg) and were 1.00 for all for the oral exposure simulations (Table 2) . Determination coefficients for other exposure scenarios were all close to 1.00, except the one between acslX and MATLAB results for the IV exposure (10 mg/kg), which was 0.86 (Table 2) . Overall, these results from the recoded models are highly correlated with the original model simulations, indicating successful translation of the original oxytetracycline model from acslX to Berkeley Madonna, MATLAB, and R language. Figures 3C and D show comparative simulations of plasma gold concentrations and liver gold amounts following a single IV injection (2 mg/kg) of gold nanoparticles in pigs between the original acslX model and our recoded models in Berkeley Madonna, MATLAB, and R language. Similar to oxytetracycline, the simulations of gold concentrations/amounts from different models were almost identical and the determination coefficients were close to 1.00 (ie, 0.96-1.00). These results suggest that we have also successfully translated the original gold nanoparticle model from acslX to Berkeley Madonna, MATLAB, and R language.
Besides determination coefficients from regression analyses, PBPK model performance can be assessed with mean absolute percentage error (MAPE) based on the following criteria: (1) acceptable prediction: MAPE < 50%; (2) good prediction: 10% < MAPE < 20%; and (3) excellent prediction: MAPE < 10% Cheng et al., 2016; Mumtaz et al., 2012a; Rayer, 2007) . As shown in Table 2 , MAPE values for all comparisons were < 10%, except the one 18.67% for gold nanoparticles between acslX and Berkeley Madonna models. These results further confirm that both the oxytetracycline and gold nanoparticle models have been successfully translated from acslX to Berkeley Madonna, MATLAB, and R language, with the simulation outputs between each other correlated well.
In the field of toxicology, currently there are no hard fast criteria for assessing the consistency of simulation results from a PBPK model coded in different programs. However, in the field of drug development, there are well-established approaches and criteria to compare whether the pharmacokinetics of 2 drugs (a reference drug and a test drug) is equivalent (FDA, 2003) . Specifically, FDA assesses bioequivalence based on pharmacokinetic endpoints such as C max (peak plasma concentration) and AUC (area under the plasma concentration time curve) that are reflective of rate and extent of absorption, respectively. In this study, we also determined the C max and AUC ratios between the recoded models and the original model based on the simulation data from Figure 3 . The purpose of our analyses was to assess the simulation performance of different models using the 2 key pharmacokinetic endpoints (C max and AUC). We found that the calculated ratios were between 81% and 100% (Table 3) .
We anticipate that performance assessment for PBPK models coded in different programs will become an issue in the future. Before the criteria of PBPK model performance assessment are established, we propose that one important check on performance of a PBPK model between different programming platforms can be carried out as follows: (1) compare the simulated concentration-time profile visually, (2) conduct regression analysis between initial model-predicted and recoded modelpredicted results, (3) calculate the MAPE value between model outputs, (4) determine the C max ratio between models, and (5) calculate the AUC ratio between models, as done in this study. Only the general differences among different program systems are listed in this Table. Please refer to the text for detailed explanation.
THE NEED FOR A TUTORIAL
Due to the wide application of PBPK models in toxicology, there are numerous review articles and textbooks on this topic (Lin et al., 2016a; Peters, 2012; Reddy et al., 2005) . However, the majority of existing works only provide theoretical descriptions of PBPK modeling methodology, without specific programming examples. As a result, it is difficult for beginners to learn programming techniques. This article represents useful examples and a structured solution to help overcome this limitation, thereby helping future students to acquire this technique. The PBPK model codes can be adapted and expanded to create new PBPK models for other chemicals or nanomaterials. The PBPK models are applicable to small molecular weight drugs or nanomaterials in different species (ie, mice, rats, dogs, pigs, and humans). The models are coded to describe multiple routes of exposure or dosing (ie, oral, IV, IM, and SC administrations), both flow-limited and membrane-limited (or diffusion-limited) compartments, as well as both single and repeated exposures. Equations for other processes, such as protein binding and hepatic metabolism, are available from the literature (Lin et al., 2011; Loccisano et al., 2012; Yang et al., 2014b; Yoon et al., 2009) and can be easily incorporated into the present models.
ADVANTAGES AND DISADVANTAGES OF EACH SOFTWARE PACKAGE IN THE IMPLEMENTATION OF PBPK MODELS INTENDED FOR RISK ASSESSMENT
There are many guidance documents for PBPK-based risk assessment (Andersen and Krishnan, 1994; EPA, 2006; Loizou et al., 2008; Thompson et al., 2008; WHO, 2010; Yang et al., 1995) . In general, the application of PBPK models in risk assessment involves 4 steps: (1) choice of critical studies; (2) selection and implementation of PBPK models; (3) evaluation of dose metrics; and (4) determination and extrapolation to human exposure levels. PBPK models should be selected to be consistent with the critical studies for deriving the point of departure in terms of the species, life stages, dose ranges, exposure routes and endpoints (dose metrics and target tissues), as well as the objectives of risk assessment. A checklist of key aspects that should be considered in selecting PBPK models for a given risk assessment has been provided in a PBPK modeling guidance document by the World Health Organization (WHO, 2010) . This article focuses on discussing the advantages and disadvantages of each software package with respect to implementation of PBPK models in risk assessment, for which typically 3 aspects should be (Baggot et al., 1978) or 100 mg/kg oral exposure (B) (Immelman, 1977) , or plasma gold concentrations (C) or liver gold amounts (D) in swine following a single 2 mg/kg IV exposure (Fent et al., 2009) . Green, red, black, and purple dashed lines represent simulation results from acslX, Berkeley Madonna, MATLAB, and R language models, respectively. The simulated concentration/amount data from different models were so close that the kinetic curves were hardly distinguishable from each other (Online figure in color.). considered, including extrapolation across exposure paradigms, among species, and characterizing the population variability. A general comparison of these 4 software packages in the implementation of PBPK models in risk assessment is provided in Table 4 and is described in detail below.
Extrapolation across exposure paradigms Extrapolation across exposure paradigms includes route-to-route, high-to low-dose, and short-to long-term (or vice versa) extrapolations. These extrapolations generally involve changing a few parameters describing the dosing scenario, such as the dose level, dosing interval, and exposure duration. This can be implemented in acslX, MATLAB, or R language by writing an executable file with the study-specific exposure parameter values to call the PBPK model to generate simulation results that are specific to a given study. In acslX, this executable file is called M script file or runtime file; in MATLAB it is a regular MATLAB file; and in R language it is just a simple R script file. In Berkeley Madonna, however, there is only 1 file, the Equation file, for the model; since extrapolation across exposure paradigms only needs to change a few parameters, this can be done by assigning new values to those parameters in the Parameter Window. Alternatively, in the Equation file, by "Commenting in and out" (ie, using curved brackets, {}, to include or exclude a section of the parameters to be used or ignored by the software during a computer simulation) of a detailed section of parameter values for a specific species and/or experimental conditions, PBPK modeling may be achieved for the study of interest. An alternative approach is to create an individual model file for each study in Berkeley Madonna.
Interspecies extrapolation
Interspecies extrapolation requires changing more parameters, including body weight, cardiac output, tissue volumes, blood flows, and depending on the needs, some chemical-specific parameters. Similar to exposure paradigm extrapolation, we can write an executable file with new parameter values to call the PBPK model to run a new species-specific simulation in acslX, MATLAB, or R language. This approach is used in a recent 
AUC, area under the concentration/amount curve from the first simulation time 0.1 h to the terminal simulation time that was dependent on the design of the selected studies (12 h for plasma OTC, 144 h for plasma AuNP, and 768 h for liver AuNP); AuNP, gold nanoparticles; C max , maximum concentration/amount during the simulation time; IV, intravenous; OTC, oxytetracycline; (1) Baggot et al. (1978) ; (2) PBPK model in acslX for risk assessment of the pesticide atrazine Campbell et al., 2016) . However, due to the many changes in the parameter values, interspecies extrapolation can also be done by creating a new model for a specific species. This approach applies to all 4 software packages discussed in this article.
Population uncertainty and variability analysis
A key aspect that must be considered in using PBPK models for risk assessment is the uncertainty and variability of pharmacokinetics and pharmacodynamics within species and between species. Population variability is a result of interindividual variations in physiology, biochemistry, and molecular biology due to genetic and environmental factors. If the distribution of each model parameter is known, population variability analysis can be conducted using Monte Carlo simulation. Monte Carlo simulation can be conveniently implemented in acslX, in which there is a module specifically for this purpose. PBPK model users simply need to select input parameters, distribution function, output parameters, and setting parameters (eg, mean, standard deviation, lower bound, and/or higher bound), thus minimal programming is required. In Berkeley Madonna, MATLAB, and R language, there is no ready-to-use module, but the model code can be revised to incorporate the distribution of each parameter, thereby generating population simulation results. Another tool that is specifically designed to conduct Monte Carlo stochastic simulations in PBPK models is GNU MCSim (Bois, 2009 ). This tool has been extensively used in PBPK model population variability analysis (Bois et al., 1996; Chiu et al., 2014; Covington et al., 2007; Lyons et al., 2008; Stamyr et al., 2015) . MCSim is written in C and, like other GNU software, can be run in a Linux operating system. A recent version of MCSim (MCSim under R) can be implemented in the R program for use on a Windows computer as part of the deSolve package (Soetaert et al., 2010) . We used the deSolve package in our models (Supplementary Data). In addition, Dr Weihsueh A. Chiu from Texas A&M University has created an alternative (using minGW) program that allows MCSim to run in a Windows system. Although population variability analysis can be conducted using Monte Carlo simulation by assigning the distributions of model parameters, in most cases the distributions of many parameters are unknown or uncertain and assumptions have to be made in order to generate population simulation results, which are of relatively high uncertainty. In PBPK models, when new data become available the prior distributions of model parameters can be updated to generate posterior distributions that more accurately represent the population characteristics of model parameters using a hierarchical Bayesian population approach with Markov chain Monte Carlo (MCMC) simulation. This approach involves the following aspects: (1) specification of the hierarchical population statistical model, (2) specification of prior distributions of model parameters; (3) estimation of the posterior distributions of model parameters using MCMC technique by incorporating newly available data; and (4) evaluation of convergence, the consistency of estimated parameters, and model fit (Chiu et al., 2014) .
In the field of toxicology and risk assessment, the most commonly used tool for MCMC analysis in PBPK models is MCSim. Detailed instructions about the software installation, implementation, and application in risk assessment are available in the User's Manual and in several recent publications (Bois, 2009; Bois et al., 1996; Chiu et al., 2014; Covington et al., 2007; Lyons et al., 2008; Stamyr et al., 2015) . Previously, MCSim could only be implemented in a Linux operating system. With the recent availability of MCSim in a Windows system and in light of the importance of MCMC analysis in the application of PBPK models in risk assessment, it is expected that the use of MCSim to conduct population variability analysis to support risk assessment will increase. MATLAB and R language can also be used to conduct MCMC analysis in PBPK models (Krauss et al., 2015; Thompson, 2012) . However, these are less commonly used compared with MCSim. In acslX, there are MC Modeler, MCMC Sampler, and example PBPK models using MCMC analysis that were specifically designed to help users to conduct MCMC analyses in PBPK models, making it an excellent software package for risk assessment. On the other hand, to the authors' knowledge, Berkeley Madonna has not been used or may not be feasible to conduct MCMC analysis.
User-friendliness and simulation time Other factors that should be considered in the development and application of PBPK models in risk assessment are the ease to learn, the user-friendliness, and the simulation time. AcslX has multiple user-friendly plugin modules that allow the user to conduct several common PBPK analyses, including sensitivity analysis, parameter estimation, and Monte Carlo analysis. Many additional reference codes are also available in the literature (Lin et al., 2016b; Yang et al., 2014b; Yoon et al., 2011) . It also has a window in its user interface showing all project files linked together that allows easy organization, navigation, and implementation of project files. Therefore, acslX was an easyto-learn PBPK modeling tool and suitable for implementation of PBPK models in risk assessment. However, the price for an academic version of acslX was much higher than that of Berkeley Madonna. The latter is also easy-to-use and has similar plugin analysis modules (ie, curve fitting, parameter estimation, and sensitivity analysis). Published PBPK model codes based on Berkeley Madonna are also available in the literature (Liang et al., 2016; Mumtaz et al., 2012b; Weijs et al., 2014) .
When compared with acslX and Berkeley Madonna, MATLAB is a more powerful high-level programming tool that is widely used by engineers and scientists across disciplines, including life science, electronics, automotive, and finance. Its prices vary depending on the version and the number of toolboxes that are included. It can be used to develop PBPK models and conduct all necessary PBPK analyses, but medium-to-high level programming is required, so it is relatively difficult to use. R language is also a powerful high-level programming platform that is used in a number of areas, especially in statistical analyses. The advantage of R language is that it is freely distributed, but R language is not commonly used to develop PBPK models at this stage.
In terms of simulation time, Berkeley Madonna is relatively faster, ie, with 1 click ("run the model"), the simulation curves for all parameters are ready to view within 1-2 s depending on the computer used (the computer used to run these simulations has an Intel Core i7-6700 Processor [Quad-Core, 8M Cache, up to 4.00 GHz] and 32 GB of RAM). MATLAB is a relatively larger program and takes a little longer time to run, but it has many different toolboxes, algorithms or solvers that can be used to optimize the code to increase the simulation speed. For example, the gold nanoparticle PBPK model in MATLAB was optimized using the conventional Euler approximation discretization method. This technique helps run the program for a fixed time step defined by dT ¼ 0.0002 (h À1 ). In this way, the optimized model ran about several times faster than the original model (the exact time of each simulation depends on the computer, MATLAB version, ODE solver, and the time step
[dT]). Both the initial and the optimized gold nanoparticle MATLAB models are provided in the Supplementary Data. Overall, to the authors' experience, Berkeley Madonna is relatively easy for beginners to get started and is sufficient to develop basic PBPK models to conduct regular PBPK analyses (eg, parameter estimation, route-to-route extrapolation, and Monte Carlo analysis). Besides the present recoding tutorial, another article specifically introducing PBPK model development using Berkeley Madonna is also available (Yang and Lu, 2007) . For experienced PBPK modelers, MATLAB and R language are more challenging, but more versatile and may be more suitable for complex projects, especially for projects involving MCMC analysis. If population variability analysis is the major goal, MCSim is recommended to be used as the procedure of using MCSim to conduct MCMC analysis in PBPK models is well documented.
Besides acslX, Berkeley Madonna, MATLAB, and R language, another general-purpose programming language that may be used to develop PBPK models is Python (Python Software Foundation, Delaware, USA). Also, while the above-described model code conversion methods should be of value for PBPK modelers, they may be less informative for risk assessors or toxicologists who only want to use PBPK models and have no or very limited programming experience. To facilitate model application by nonmodelers, one way is to convert a code-based PBPK model to a graphical user interface (GUI). In this regard, MATLAB, Shiny (a web application framework for R), and Python all have GUI development capabilities. A discussion of the detailed method of GUI development is beyond the scope of this article, but a general procedure based on MATLAB is provided in the Supplementary Data. In addition to the generalpurpose programming tools, PBPK models can also be developed using custom software such as Simcyp Simulator (Certara, Princeton, New Jersey, USA) and GastroPlus (Simulations Plus, Inc., Lancaster, California, USA). These commercial proprietary software systems are commonly used to develop PBPK models for use in drug discovery and development. They can also be used to conduct in vitro to in vivo extrapolation and develop PBPK models for environmental chemicals and drugs to aid toxicity assessment (Adeleye et al., 2015; Bois et al., 2010; Wetmore et al., 2012) .
FUTURE PERSPECTIVE
The issues and challenges in the development and application of PBPK models for risk assessment have been discussed in another forum article (McLanahan et al., 2012) . This article focuses on the impact of the unavailability of acslX in the implementation of PBPK models in risk assessment, which obviously requires learning a new software package to recode published models or to develop a new model for future applications. In this regard, the present tutorial can help minimize this impact. In addition, from a broader view in terms of future direction in this field, some thoughts to consider include.
Training
Besides this tutorial, another direct approach to address the impact of unavailability of acslX is to offer hands-on training on other PBPK modeling software packages to individuals who previously used acslX and have not yet used other tools. In this regard, the PBPK workshops offered by Dr Raymond S.H. Yang at Colorado State University and by a group of PBPK modelers at ScitoVation offer excellent opportunities to receive relevant training using Berkeley Madonna. However, these workshops are typically short-term (ie, approximately 1 week), thus the participants can learn the concepts and have some basic handson practice, but there is not enough time to complete a whole project. The long-term goal of training should be to include a PBPK modeling course in university curricula, similar to what Dr Jeffrey W. Fisher did at The University of Georgia. In this aspect, a semester-based PBPK modeling course has been approved and will be offered through Kansas State University Global Campus. The objective of this course is to provide longer-term systematic PBPK modeling training and it is expected that each student should complete a whole PBPK modeling project by the end of the semester.
Education
Besides the short-term or longer-term training, the establishment of graduate education programs focusing on PBPK and other related pharmacokinetic modeling training in academic institutions is highly encouraged and is in great need. PBPK modeling and application are specialized techniques and becoming more and more widely used in various fields that would require more and more competent PBPK modelers.
Sharing
As pointed out by other PBPK modelers, it is critical and necessary to publish PBPK model codes for subsequent model applications. More and more PBPK models have published their codes along with the articles (Liang et al., 2016; Lin et al., 2016c; Weijs et al., 2014; Yang et al., 2014b; Yoon et al., 2011) , but there are many others that do not. The sharing of model codes, especially codes in different software packages, is important for PBPK modelers to learn different programming languages, and this will definitely advance this field.
Collaboration
With the ever increasingly competitive funding situations, nowadays there are few academic laboratories that solely focus on PBPK model development and application because simply proposing to develop a PBPK model does not justify a grant support and without grants academic laboratories cannot maintain. Collaboration between industrial, governmental, and academic institutions on projects involving PBPK modeling is highly recommended to maintain support for research, training, and application of PBPK models in academia.
The essence of systems biology Despite the fact that PBPK modeling is a relatively mature technology, new applications and research opportunities continue to appear on the horizon. If one traces the development of systems biology back to the teachings of Wiener (1948) , one would perceive that PBPK modeling possesses the essence of systems biology in the integration of biomedical sciences with mathematics, physics, engineering, and "computing machines." In that regard and as a case in point for the application of PBPK modeling, the recent advances in environmental carcinogenesis in the "Halifax Project" where a major effort by some 200 cancer biologists and toxicologists, working on the basis of the 11 hallmarks of cancer, concluded that low-dose exposures of mixtures of environmental pollutants, which work in concert, may induce environmental carcinogenesis (Goodson et al., 2015) . PBPK, with the incorporation of pharmacodynamic modeling, would be an ideal platform for conducting these types of complicated experiments on computers. Pushing the envelope further, artificial intelligence may very well play an active role in such endeavors.
In summary, the present PBPK model recoding methods fill a gap in the pharmacological and toxicological literature. This article provides a tutorial for beginners to learn PBPK modeling techniques, assesses the simulation performance for PBPK models coded in different software programs, presents a general comparison of each software package in the implementation of PBPK models in risk assessment, offers suggestions for PBPK modelers to select a suitable alternative modeling tool for future projects, and may help facilitate the transition from acslX to alternative modeling tools (eg, Berkeley Madonna, MATLAB, and R language) in the PBPK modeling community.
SUPPLEMENTARY DATA
Supplementary data are available at Toxicological Sciences online.
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